Humza Saeed, Abdullah, Hira Hameed, Hafiz Mohammad Maaz, Abdul Wasay, Zubair Amin, Muhammad Khubaib Arshad, Hritvik Jain, Aman Goyal
{"title":"美国成人亨廷顿舞蹈病的死亡率趋势和差异。","authors":"Humza Saeed, Abdullah, Hira Hameed, Hafiz Mohammad Maaz, Abdul Wasay, Zubair Amin, Muhammad Khubaib Arshad, Hritvik Jain, Aman Goyal","doi":"10.1177/18796397241287399","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Huntington's disease (HD), an autosomal dominant disorder, is characterized by progressive neurodegeneration, psychiatric issues, dementia, and worsening chorea over time. Its prevalence varies by ethnicity and region.</p><p><strong>Objective: </strong>This study aims to analyze mortality trends and disparities in adults with HD in the United States (US).</p><p><strong>Methods: </strong>This study analyzed death certificates from 1999 to 2020 for deaths due to HD (ICD-10 code G10) in individuals aged 25 and older. Age-adjusted mortality rates (AAMRs) and annual percent change (APC) were calculated by year, gender, age groups, race/ethnicity, geographics and urbanization status.</p><p><strong>Results: </strong>Between 1999 and 2020, there were 24,121 reported deaths among patients with HD. During this period, the AAMR increased from 4.3 to 6.0 per 1,000,000 population, with a notable surge from 2018 to 2020 (APC: 9.88; 95% CI: 5.45 to 13.20). Older adults exhibited the highest AAMRs at 10.4 per 1,000,000 when analyzed by age-group. Men and women had comparable AAMRs (5.2 vs. 5.0). By race, non-Hispanic (NH) Whites had the highest AAMRs (6.0), followed by NH African Americans (3.3) and Hispanics (2.8). Additionally, non-metropolitan areas experienced higher AAMRs compared to metropolitan areas (6.6 vs. 4.8).</p><p><strong>Conclusions: </strong>Since 1999, mortality from HD has increased, particularly from 2018 to 2020, with higher rates in older adults, men, NH Whites, and non-metropolitan areas. Further research is essential to consolidate data, standardize reporting practices, and address disparities to improve outcomes.</p>","PeriodicalId":16042,"journal":{"name":"Journal of Huntington's disease","volume":"13 4","pages":"491-500"},"PeriodicalIF":2.1000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mortality trends and disparities in adults with Huntington's disease in the United States.\",\"authors\":\"Humza Saeed, Abdullah, Hira Hameed, Hafiz Mohammad Maaz, Abdul Wasay, Zubair Amin, Muhammad Khubaib Arshad, Hritvik Jain, Aman Goyal\",\"doi\":\"10.1177/18796397241287399\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Huntington's disease (HD), an autosomal dominant disorder, is characterized by progressive neurodegeneration, psychiatric issues, dementia, and worsening chorea over time. Its prevalence varies by ethnicity and region.</p><p><strong>Objective: </strong>This study aims to analyze mortality trends and disparities in adults with HD in the United States (US).</p><p><strong>Methods: </strong>This study analyzed death certificates from 1999 to 2020 for deaths due to HD (ICD-10 code G10) in individuals aged 25 and older. Age-adjusted mortality rates (AAMRs) and annual percent change (APC) were calculated by year, gender, age groups, race/ethnicity, geographics and urbanization status.</p><p><strong>Results: </strong>Between 1999 and 2020, there were 24,121 reported deaths among patients with HD. During this period, the AAMR increased from 4.3 to 6.0 per 1,000,000 population, with a notable surge from 2018 to 2020 (APC: 9.88; 95% CI: 5.45 to 13.20). Older adults exhibited the highest AAMRs at 10.4 per 1,000,000 when analyzed by age-group. Men and women had comparable AAMRs (5.2 vs. 5.0). By race, non-Hispanic (NH) Whites had the highest AAMRs (6.0), followed by NH African Americans (3.3) and Hispanics (2.8). Additionally, non-metropolitan areas experienced higher AAMRs compared to metropolitan areas (6.6 vs. 4.8).</p><p><strong>Conclusions: </strong>Since 1999, mortality from HD has increased, particularly from 2018 to 2020, with higher rates in older adults, men, NH Whites, and non-metropolitan areas. Further research is essential to consolidate data, standardize reporting practices, and address disparities to improve outcomes.</p>\",\"PeriodicalId\":16042,\"journal\":{\"name\":\"Journal of Huntington's disease\",\"volume\":\"13 4\",\"pages\":\"491-500\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Huntington's disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/18796397241287399\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Huntington's disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/18796397241287399","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/8 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
摘要
背景:亨廷顿舞蹈病(HD)是一种常染色体显性遗传病,其特征是进行性神经退行性变、精神问题、痴呆和舞蹈病随着时间的推移而恶化。其流行程度因种族和地区而异。目的:本研究旨在分析美国成人HD患者的死亡率趋势和差异。方法:本研究分析了1999年至2020年25岁及以上人群因HD (ICD-10代码G10)死亡的死亡证明。年龄调整死亡率(AAMRs)和年变化百分比(APC)按年份、性别、年龄组、种族/民族、地理位置和城市化状况计算。结果:1999年至2020年间,有24121例HD患者死亡。在此期间,AAMR从每100万人口4.3增加到6.0,从2018年到2020年显著增加(APC: 9.88;95% CI: 5.45 - 13.20)。按年龄组分析,老年人的aamr最高,为每100万人10.4个。男性和女性的aamr相当(5.2 vs 5.0)。按种族划分,非西班牙裔(NH)白人的aamr最高(6.0),其次是NH非裔美国人(3.3)和西班牙裔(2.8)。此外,非大都市地区的aamr高于大都市地区(6.6比4.8)。结论:自1999年以来,HD的死亡率有所增加,特别是从2018年到2020年,老年人、男性、NH白人和非大都市地区的死亡率更高。进一步的研究对于整合数据、标准化报告实践和解决差异以改善结果至关重要。
Mortality trends and disparities in adults with Huntington's disease in the United States.
Background: Huntington's disease (HD), an autosomal dominant disorder, is characterized by progressive neurodegeneration, psychiatric issues, dementia, and worsening chorea over time. Its prevalence varies by ethnicity and region.
Objective: This study aims to analyze mortality trends and disparities in adults with HD in the United States (US).
Methods: This study analyzed death certificates from 1999 to 2020 for deaths due to HD (ICD-10 code G10) in individuals aged 25 and older. Age-adjusted mortality rates (AAMRs) and annual percent change (APC) were calculated by year, gender, age groups, race/ethnicity, geographics and urbanization status.
Results: Between 1999 and 2020, there were 24,121 reported deaths among patients with HD. During this period, the AAMR increased from 4.3 to 6.0 per 1,000,000 population, with a notable surge from 2018 to 2020 (APC: 9.88; 95% CI: 5.45 to 13.20). Older adults exhibited the highest AAMRs at 10.4 per 1,000,000 when analyzed by age-group. Men and women had comparable AAMRs (5.2 vs. 5.0). By race, non-Hispanic (NH) Whites had the highest AAMRs (6.0), followed by NH African Americans (3.3) and Hispanics (2.8). Additionally, non-metropolitan areas experienced higher AAMRs compared to metropolitan areas (6.6 vs. 4.8).
Conclusions: Since 1999, mortality from HD has increased, particularly from 2018 to 2020, with higher rates in older adults, men, NH Whites, and non-metropolitan areas. Further research is essential to consolidate data, standardize reporting practices, and address disparities to improve outcomes.